Literature DB >> 2213080

Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study.

A J Lee1, W C Smith, G D Lowe, H Tunstall-Pedoe.   

Abstract

Plasma fibrinogen was measured in a sample of 8824 men and women aged 40-59 years participating in the Scottish Heart Health Study, and related to cardiovascular risk factors. Women had higher fibrinogen levels than men. In both sexes, multivariate analysis showed that fibrinogen was positively associated with age, smoking, total cholesterol and body mass index and negatively associated with alcohol consumption. Among women, early menopause and systolic blood pressure were also associated with fibrinogen levels. Univariate analyses showed weak positive associations with fish consumption for both sexes although only male white fish consumption entered the final model. Women with a history of contraceptive pill usage had significantly lower fibrinogen levels. The relationship between fibrinogen and physical activity was complex, and could largely be explained by smoking. These findings support the hypothesis that raised fibrinogen is one mechanism by which several major risk factors may promote coronary heart disease. However, known risk factors explained, at most, 10% of the total variance in fibrinogen levels among the general population.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213080     DOI: 10.1016/0895-4356(90)90075-z

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  26 in total

1.  Genetic variation at fibrinogen loci and plasma fibrinogen levels.

Authors:  J M Connor; F G Fowkes; J Wood; F B Smith; P T Donnan; G D Lowe
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

2.  Physical activity, physical fitness, blood pressure, and fibrinogen in the Northern Ireland health and activity survey.

Authors:  D MacAuley; E E McCrum; G Stott; A E Evans; B McRoberts; C A Boreham; K Sweeney; T R Trinick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

3.  Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.

Authors:  Mira Harrison-Woolrych; Linda Härmark; Ming Tan; Simran Maggo; Kees van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2012-02-08       Impact factor: 2.953

4.  Fibrinogen.

Authors:  E Ernst
Journal:  BMJ       Date:  1991-09-14

5.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

6.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

Review 7.  Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness.

Authors:  Non Eleri Thomas; Julien S Baker; Bruce Davies
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 8.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

9.  The Dundee coronary risk-disk for management of change in risk factors.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1991-09-28

10.  Strenuous exercise, plasma fibrinogen, and factor VII activity.

Authors:  J B Connelly; J A Cooper; T W Meade
Journal:  Br Heart J       Date:  1992-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.